KABIR ALI: Open Payments
NPI 1790181014 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 16 payments from 7 companies in 2025. Trend: 2023 $66 · 2024 $482 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $131 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $104 |
| Kestra Medical Technology Services, Inc. | 4 | $66 |
| Merck Sharp & Dohme LLC | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| CVRx, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $21 |
Products named: INGREZZA, LifeVest, Assure WCD, VERQUVO, FARXIGA, Barostim Neo System.
Industry payments across GA — which companies pay providers there.
